Search Within

Weisheng Xu

  1. "Lang Ngo"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (4)
Groups
  1. Adult Leukemia (2)
  2. Cell Biology Program Faculty (2)
  3. Center for Hematologic Malignancies (2)
  4. GSK Faculty (2)
  5. Sloan Kettering Institute Faculty (2)
People
  1. Lang Ngo (9)
  2. Paul Marks (9)
  3. Gisela Venta-Perez (7)
  4. Milos Dokmanovic (5)
  5. Chang-Yun Gui (4)
  6. Dharmarao Thapi (2)

More People

Years
  1. 2007 (1)
  2. 2006 (2)
  3. 2005 (3)
  4. 2004 (3)
Publications
  1. Cancer Research (5)
  2. Proceedings of the National Academy of Sciences of the United States of America (3)
  3. Molecular Cancer Therapeutics (1)
Publishers
  1. American Association for Cancer Research (6)
  2. National Academy of Sciences (3)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Histone deacetylase inhibitors selectively suppress expression of HDAC7
    Journal Article

    Dokmanovic, M.; Perez, G.; Xu, W.; Ngo, L.; Clarke, C.; Parmigiani, R. B.; Marks, P. A.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Role of pro- and anti-apoptotic proteins in prostate cancer cells sensitive and resistant to histone deacetylase inhibiton induced cell death
    Meeting Abstract

    Xu, W.; Ngo, L.; Perez, G.; Dokmanovic, M.; Marks, P. A.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor
    Journal Article

    Xu, W.; Ngo, L.; Perez, G.; Dokmanovic, M.; Marks, P. A.
    Proceedings of the National Academy of Sciences of the United States of America (2006)

    Fulltext@MSK | Save
  • Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitor
    Meeting Abstract

    Ungerstedt, J. S.; Sowa, Y.; Xu, W.; Shao, Y.; Dokmanovic, M.; Perez, G.; Ngo, L.; Holmgren, A.; Jiang, X.; Marks, P. A.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Induction of polyploidy by histone deacetylase inhibitor: A pathway for antitumor effects
    Journal Article

    Xu, W. S.; Perez, G.; Ngo, L.; Gui, C. Y.; Marks, P. A.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors
    Journal Article

    Ungerstedt, J. S.; Sowa, Y.; Xu, W. S.; Shao, Y.; Dokmanovic, M.; Perez, G.; Ngo, L.; Holmgren, A.; Jiang, X.; Marks, P. A.
    Proceedings of the National Academy of Sciences of the United States of America (2005)

    Fulltext@MSK | Save
  • Induction of mitotic defect is a novel anti-tumor mechanism of histone deacetylase inhibitor suberoylanilide hydroxamic acid
    Meeting Abstract

    Xu, W.; Perez, G.; Gui, C.; Thapi, D.; Ngo, L.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitor activation of p21 involves changes in promoter associated proteins, including HDAC1
    Meeting Abstract

    Gui, C.; Ngo, L.; Xu, W.; Thapi, D.; Perez, G. V.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1
    Journal Article

    Gui, C. Y.; Ngo, L.; Xu, W. S.; Richon, V. M.; Marks, P. A.
    Proceedings of the National Academy of Sciences of the United States of America (2004)

    Fulltext@MSK | Save